Khosla, VCs plow US$100m into blood test startup using AI

Khosla, VCs plow US$100m into blood test startup using AI
(Image: Bloomberg)
Bloomberg
(Bloomberg) -- Blood-testing company Karius Inc. raised US$100 million (NZ$166.8m) in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals. The funding round was led by existing investor Khosla Ventures alongside 5AM Ventures and Gilde Healthcare. The company declined to give its valuation. Redwood City, California-based Karius’ blood tests look for pathogens by comparing fragments of microbial DNA with a database of 20,000 genomic reference...

More Technology

Daisy Lab gets green light to scale up GMO trials
News in Brief

Daisy Lab gets green light to scale up GMO trials

The start-up is still bound by strict rules to work in a contained facility.

Greg Hurrell 16 May 2024
Is Roaring Kitty the internet’s Warren Buffett?
Technology

Is Roaring Kitty the internet’s Warren Buffett?

GameStop’s high valuations might influence the market.

Irish lessons – Tech's place in NZ's future
Technology Free Business of Tech podcast

Irish lessons – Tech's place in NZ's future

Primary exports can only take an economy so far.